Oktoba 30, 2022, asibitin Intanet na Lafiya na Baidu (wanda ake kira "Baidu Health") da Shanghai Epiprobe Biotechnology Co., Ltd. (wanda ake kira "Epiprobe") sun ba da sanarwar haɗin gwiwar dabarun don yada farkon gwajin cutar kansa a cikin asibiti da na gaba ɗaya. Tashoshin lafiya yayin bikin bude dakin gwaje-gwaje na Epiprobe Biomedical da aka gudanar a birnin Heze, lardin Shandong.
Mr. Zhang Kuan, shugaban asibitin Intanet na Lafiya ta Baidu, Madam Hua Lin, shugabar kamfanin Epiprobe, da sauran su sun shaida bikin sanya hannu kan dabarun hadin gwiwa.Kiwon lafiya na Baidu da Epiprobe za su yi amfani da kowace fa'ida, haɗa sabis na kan layi da na layi, haɓaka gwajin cutar kansa da wuri da ganewar asali, da kuma bincika haɗaɗɗen sabis na kiwon lafiya tun daga rigakafin cutar kansa zuwa sanannen kimiyya zuwa gwajin farko a fagage daban-daban.
Bisa kididdigar da aka samu, yawan kudaden da ake kashewa a fannin likitanci na cututtukan daji na shekara-shekara ya zarce RMB biliyan 220, wanda ya zama wani muhimmin bangare na ciyar da iyalai da kudaden inshorar likitanci a kasar Sin.A cewar Frost & Sullivan, za a kara kudin maganin cutar kansa zuwa dala biliyan 351.7 a shekarar 2023 da dala biliyan 592 a shekarar 2030 a kasar Sin.Binciken cutar kansa da wuri da ganewar asali ya inganta rayuwar marasa lafiya sosai, wanda kuma ya rage nauyin kashe kuɗin kula da lafiya ga ƙasashe da daidaikun mutane.Asibitin ciwon daji na Kwalejin Kimiyyar Kiwon Lafiyar Jama'a ta kasar Sin ya fitar da wata takarda cewa, gwajin cutar kansa da wuri zai iya hana kamuwa da cutar kansa da cutar kansa.Don haka, Kiwon Lafiyar Baidu ya yi haɗin gwiwa tare da Epiprobe don aiwatar da gano cutar kansa da wuri, ganewar farko da magani da wuri.
Kiwon lafiya na Baidu, babban dandalin tuntubar kiwon lafiya wanda Baidu ya kirkira, yana yiwa ma'aikatan kiwon lafiya sama da miliyan 100 hidima a kullum tare da madaidaitan bincike sama da miliyan 200 na likita da kiwon lafiya.Sama da likitoci 300,000 a asibitocin gwamnati suna ba abokan ciniki sabis na tuntuɓar likitancin kan layi miliyan 2.4 ta hanyar dandamali a kullun.
A matsayin babbar hanyar shiga masu amfani don koyo game da ilimin kiwon lafiya, abokan ciniki miliyan 100 a kullum suna samun ilimin kiwon lafiya da sabis ta hanyar Baidu Health.A halin yanzu, Kiwon Lafiyar Baidu ya kafa tsarin tuntuɓar kimiyyar lafiya ta hanyar Baidu Health Codex, Baidu Health Baijia da tambayoyi masu ƙarfi na likitoci, wanda ya tattara tarin abubuwan kimiyyar lafiya miliyan 500.Abubuwan da ke cikin ilimin kimiyyar lafiya sun ƙunshi duk tsarin rigakafi, ganewar asali, jiyya, gyarawa da kula da lafiya.Mr. Zhang Kuan, shugaban asibitin Intanet na Lafiya ta Baidu, ya lura cewa: "Tun lokacin da aka kafa, Kiwon Lafiyar Baidu, tare da himma wajen karfafa masana'antar kiwon lafiya ta hanyar binciken manyan bayanai da kuma fa'idar fasahar AI, tana ba da hadin gwiwa sosai tare da masana'antun sarrafa kwayoyin halitta, da samar da ayyukan yi. dandali don ciyar da sababbin samfuran fasaha don cimma cikakkiyar haɓakawa da aikace-aikace.Muna fatan za mu yi cikakken amfani da zirga-zirgar dandamali da fa'idodin fasaha, damar sabis na kiwon lafiya ta tsaya ɗaya, da kuma bincika samfurin sabis na gwajin cutar kansa na farko tare da Epiprobe, don ƙarin. abokan ciniki za su iya fahimtar ƙima da mahimmancin tantancewa da wuri, tare da gina tsarin sabis na gwajin farko na ƙasa wanda ke haɗa kan layi da layi, da kuma haɗa hanyoyin rigakafi da magance maganin ƙwararrun ƙwararrun ƙwararrun ƙwararrun asibitoci, ta haka ne ke ba da cikakken tsari da sabis na tsayawa ɗaya. na rigakafin cutar kansa da jiyya, haɓaka masana'antar kiwon lafiya tare da dijital. ”
A matsayinsa na majagaba na fara gwajin cutar sankara, Epiprobe babban kamfani ne na fasaha wanda ke mai da hankali kan gano ƙwayoyin ƙwayoyin cuta na kansa da ingantattun masana'antar magunguna.Gina kan ƙwararrun ƙwararrun ƙwararrun ƙwararrun epigenetics tare da zurfin bincike na ilimi sama da shekaru 30, Epiprobe ya bincika fagen gano cutar kansa, ya tabbatar da hangen nesa na “kyauta kowa da kowa daga cutar kansa,” wanda ya himmatu ga gano farkon, ganewar asali da farkon magani. ciwon daji, don haka inganta yawan rayuwar masu fama da cutar kansa don inganta lafiyar jama'a.
Madam Hua Lin, shugabar kamfanin Epiprobe ta lura da cewa: “Ana yin gwajin farko don samun ingantacciyar tantancewa kafin kamuwa da cutar kansa, kuma a halin yanzu amfani da alamomin cutar sankara don tantancewa da wuri ya sami nasarar tantance cutar da wuri da kuma sa ido sosai, wanda zai iya taimakawa likitoci su shiga tsakani. da kuma kawar da ciwon daji a matakin farko, ta haka musamman kara yawan rayuwar marasa lafiya da rage farashin magani."hangen nesa na Epiprobe shine 'Gina Duniyar da ba ta da Ciwon daji,' wanda kuma ke nuna amincewarmu da ƙudurinmu a farkon gwajin cutar kansa. Kasuwanni na asibiti, ƙirƙirar keɓaɓɓen tsarin sabis mai zurfi na tsaye ga abokan ciniki Har ila yau, Epiprobe yana ba da cikakkiyar sabis a aikace-aikacen asibiti kamar gwajin cutar kansa, bincike na taimako, ƙididdigar ƙima da sa ido kan sake dawowar inganci, ta haka ne ke samun dukkan tsarin ayyukan kiwon lafiya daga ' gano cutar daji da wuri' don 'kariyar rigakafin ciwon daji a gaba.'"
Lokacin aikawa: Oktoba-30-2022